Ramucirumab

ATC L01FG02 · 10 markets · 21 records

Ramucirumab 10 markets · 21 records Forms

GB 4 records · 2 strengths

500 mg/50 mLinjectionCyramza 500mg/50ml concentrate for solution for infusion vials also in CN
100 mg/10 mLinjectionCyramza 500mg/50ml concentrate for solution for infusion vials also in CN

ES 4 records · 1 strengths

10 mg/1 mLinjectionCYRAMZA

US 2 records · 1 strengths

10 mgliquidCYRAMZA also in CA

SG 2 records · 1 strengths

10 mg/mLinjectionCYRAMZA CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/10ML

CN 2 records · 2 strengths

500 mg/50 mLinjection希冉择雷莫西尤单抗 also in GB
100 mg/10 mLinjection希冉择雷莫西尤单抗 also in GB

CA 1 records · 1 strengths

10 mgliquidCYRAMZA also in US

TW 1 records · 1 strengths

Records without a stated strength · 1 CYRAMZA、欣銳擇注射劑

HK 1 records · 1 strengths

Records without a stated strength · 1 CYRAMZA CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/10ML

EU 1 records · 1 strengths

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Records without a stated strength · 1 CYRAMZA

Side-by-side table

Strength / form / release	US	GB	CA	SG	CN	ES	TW	HK	EU
10 mg liquid	CYRAMZA	not recorded	CYRAMZA	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
500 mg/50 mL injection	not recorded	Cyramza 500mg/50ml concentrate for solution for infusion vials	not recorded	not recorded	希冉择雷莫西尤单抗	not recorded	not recorded	not recorded	not recorded
100 mg/10 mL injection	not recorded	Cyramza 500mg/50ml concentrate for solution for infusion vials	not recorded	not recorded	希冉择雷莫西尤单抗	not recorded	not recorded	not recorded	not recorded
10 mg/1 mL injection	not recorded	not recorded	not recorded	not recorded	not recorded	CYRAMZA	not recorded	not recorded	not recorded
10 mg/mL injection	not recorded	not recorded	not recorded	CYRAMZA CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/10ML	not recorded	not recorded	not recorded	not recorded	not recorded
not disclosed injection	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	CYRAMZA 欣銳擇注射劑	not recorded	not recorded
not disclosed unknown	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	CYRAMZA CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/10ML	CYRAMZA

Scroll horizontally for more markets →

Each country column shows the locally registered trade names — not translations.

4 more strength/form rows are recorded only in SG · ES · TW · HK · EU and are not shown in this table. Hay 4 filas de concentración/forma registradas solo en SG · ES · TW · HK · EU que no se muestran en esta tabla. 另有 4 个规格/剂型仅在 SG · ES · TW · HK · EU 有记录（未在本表显示）。另有 4 個規格/劑型僅在 SG · ES · TW · HK · EU 有記錄（未在本表顯示）。

“not disclosed” means the source does not publish the strength — it does not mean the product has none.

Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Back to the list

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.